MODULATOR ASSAY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110319287A1
SERIAL NO

13145248

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates inter alia to methods for identifying modulators of tumour necrosis factor (TNF) signalling. In one aspect, the method involves identifying an agent that modulates a signalling pathway mediated by TNF, comprising the steps of providing a host cell comprising TNF receptor 1 (TNFR1)-associated death domain (TRADD) linked to a reporter molecule, and determining at least one cellular characteristic detectable by the reporter molecule in the host cell in the presence of TNF and in the presence and absence of a candidate modulator. The invention is suitable for high-throughput screening (HTS) and high-content screening (HCS), or a combination of HTS and HCS.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ADDEX PHARMA S A1202 GENÈVE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chedal-bornu, goiller Aurelie Florence Plan-les-Ouates, CH 1 0
Luetjens, Robert Johannes Plan-les-Ouates, CH 1 0
Mutel, Vincent Plan-les-Ouates, CH 43 643

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation